Understanding how cell recycling affects Type 1 Diabetes development
Characterizing the Role of Autophagy in Type 1 Diabetes Development
This study is looking at how a natural recycling process in our cells might affect the health of insulin-producing cells in the pancreas, which could help us find new ways to treat Type 1 Diabetes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11071594 on NIH RePORTER |
What this research studies
This research investigates the role of autophagy, a cellular recycling process, in the development of Type 1 Diabetes (T1D). It focuses on how defects in this process may lead to the destruction of insulin-producing beta cells in the pancreas. By studying mice with specific genetic modifications, the researchers aim to understand how impaired autophagy affects beta cell health, immune responses, and the formation of proteins that may trigger autoimmune reactions. The findings could provide insights into new therapeutic strategies for T1D.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old who are at risk for developing Type 1 Diabetes or have early signs of the disease.
Not a fit: Patients who are older than 11 years or those with established Type 1 Diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that protect beta cells and slow or prevent the onset of Type 1 Diabetes.
How similar studies have performed: Other research has shown promising results in targeting cellular processes like autophagy for various autoimmune diseases, suggesting potential for success in this area as well.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Austin, Matthew — Indiana University Indianapolis
- Study coordinator: Austin, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.